Eczema Free Forever™ Eczema Free Forever™

Repurposed antifungal exhibits promising results

A novel oral formulation of itraconazole designed to improve bioavailability is leveraging its activity as a Hedgehog pathway inhibitor to provide a low toxicity, effective treatment for patients with BCC Nevus Syndrome. Data show potential for rapid therapeutic benefit.
Dermatology Times – Dermatology

Eczema Drug Shows Promising Phase 2 Results for Treatment of Eosinophilic Esophagitis – AJMC.com Managed Markets Network

Eczema Drug Shows Promising Phase 2 Results for Treatment of Eosinophilic Esophagitis
AJMC.com Managed Markets Network
This new study suggests that dupilumab's ability to quickly reduce inflammation, which makes it so effective in clearing up atopic dermatitis (eczema), appears to be at work in reversing type 2 inflammation in eosinophilic esophagitis. Dupilumab works

eczema – Google News

Eczema Drug Shows Promising Phase 2 Results for Treatment of Eosinophilic Esophagitis – AJMC.com Managed Markets Network

Eczema Drug Shows Promising Phase 2 Results for Treatment of Eosinophilic Esophagitis
AJMC.com Managed Markets Network
This new study suggests that dupilumab's ability to quickly reduce inflammation, which makes it so effective in clearing up atopic dermatitis (eczema), appears to be at work in reversing type 2 inflammation in eosinophilic esophagitis. Dupilumab works

eczema – Google News

Phase 3 trials for acne treatment show promising results

The tetracycline-derived antibiotic sarecycline from Allergan plc and Paratek Pharmaceuticals Inc. for the treatment of moderate-to-severe acne has been found effective and safe, according to the results of two phase 3 trials.
Dermatology Times – Dermatology